Novartis' FCA Suit Discovery Request Slammed By States
By Khadijah M. Britton · September 30, 2014, 5:57 PM EDT
California, New York, New Jersey and eight other states on Monday challenged Novartis Pharmaceutical Corp.'s bid for information on their medication adherence programs, saying the information is irrelevant to a whistleblower...
To view the full article, register now.